← Open Payments lookup

MOHAMED ALHENNAWY: Open Payments

NPI 1417649377 · WAYNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,710 in 74 payments from 14 companies in 2025. Trend: 2023 $351 · 2024 $1,351 · 2025 $1,710

Food & beverage: $1,710
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.10$378
ABBVIE INC.19$324
Alkermes, Inc.11$297
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$207
Neurocrine BioSciences, Inc.5$93
Teva Pharmaceuticals USA, Inc.5$82
Almatica Pharma LLC4$69
Axsome Therapeutics, Inc.4$61
Lundbeck LLC3$53
Takeda Pharmaceuticals U.S.A., Inc.2$35

Products named: VRAYLAR, REXULTI, CAPLYTA, LYBALVI, ABILIFY MAINTENA, INGREZZA, ARISTADA, LOREEV XR.

Industry payments across NJ — which companies pay providers there.